ImevaX is a Biotech company based in Munich with a focus on facilitating H. pylori Diagnostics with a novel Rapid Diagnostic Test.
Pylori DuoTect® H. pylori Rapid Test is an in vitro immunochromatographic assay for the qualitative detection of antibodies specific to two Helicobacter Pylori (H. pylori) antigens in human whole blood, serum or plasma: FliD and CagA. The assay is intended to be used in first-line diagnostics to detect a H. pylori infection in adult subjects.
Company Details
- Founded
- -
- Address
- Sendlinger Straße 60, München,bayern 80331,germany
- Phone
- (498) 941-4245
- in****@****vaX.com
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- imevax.com
- Keywords
- Helicobacter pylori, First-line Screening, IVD, H. pylori diagnostics, Immunoassays, Lateral Flow Tests, Antibody Tests, Rapid Diagnostic Tests, Serology, Gastritis, Stomach diseases.
- HQ
- München, Bayern
Imevax Gmbh Questions
Imevax Gmbh's helpline number is (498) 941-4245
Imevax Gmbh's website is imevax.com
Imevax Gmbh's LinkedIn profile is https://de.linkedin.com/company/imevax-gmbh
Imevax Gmbh's industry is
Biotechnology Research
Imevax Gmbh's top competitors are
Catalym Gmbh,
Project Pharmaceutics Gmbh,
Systasy Bioscience Gmbh,
Bruker Biosensors,
Coriolis Pharma,
Isarna Therapeutics Gmbh,
Leukocare Ag,
Pieris Pharmaceuticals,
Scirhom,
Iomx Therapeutics Ag.
Imevax Gmbh's support email address is info@ImevaX.com
Imevax Gmbh's categories are Biotechnology Research
Imevax Gmbh's founding year is 2013
